Electronic cigarettes as a harm reduction strategy among patients with COPD: protocol for an open-label two arm randomized controlled pilot trial.
Elizabeth R StevensLei LeiCharles M ClelandMahathi VojjalaOmar El-ShahawyKenneth I BergerThomas R KirchnerScott E ShermanPublished in: Addiction science & clinical practice (2022)
Despite decades of availability of smoking cessation medications, nearly half of people with COPD still smoke. This study aims to address the unmet need for feasible and effective strategies for reducing CC use among those with COPD, which has the potential to significantly improve the health of people with COPD who smoke. Trial Registration ClinicalTrials.gov Identifier: NCT04465318.